Health Care: Drugs

Cambrex Corporation (CBM: NYSE)

$13.16 0.03 | 0.23%
05/17/13 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 13.16
52 Week High 14.33
52 Week Low 6.74
Avg. Daily Vol. (Mil) 0.17
Beta (3 year) 0.68
Share Related Items
Mkt Cap (Mil) 395.22
Shares Out (Mil) 30.03
Float (Mil) 26.17
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 2.00
LT Debt/ Equity 0.43
Total Debt / Equity 0.43
Valuation Ratios
Price Earnings 6.00
Price/Sales 1.40
Price/Book 2.30
Price/Cash Flow 4.50
Per Share Data
Earnings 2.19
Sales 9.37
Book Value 5.72
Cash Flow 2.93
Business Summary
Cambrex Corporation is a life sciences company that provides essential products and services to accelerate drug discovery, development and manufacturing processes for human therapeutics.
General Information
One Meadowlands Plaza
East Rutherford, NJ 07073
www.cambrex.com
Industry : Drugs
Sector: Health Care
Employees: 891
CEO: Steven M. Klosk
Short Interest
Current Month (Mil) 0.47
Previous Month (Mil) 0.38
Short Interest Ratio (Days) 3.40
Management Effectiveness
Return on Equity 38.70
Return on Assets 16.20
Return on Investments 27.10
Profitability
Gross Margin 40.70
EBIT Margin 14.10
Profit Margin 23.60

Portfolios with CBM

Latest CBM Headlines from TheStreet

More Financial News for CBM

Press Releases for CBM

See All Press Releases

Partner Headlines for CBM

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter